Healthcare & Life Sciences

Our team has many years of experience in acting on behalf of participants in the healthcare & life science sectors, including on behalf of pharmaceutical companies, biotechs, medical device manufacturers, digital health companies, IVF providers, pharmacies, investors and venture capital funds.

Our multi-disciplinary team includes independently recognised lawyers practicing in areas such as mergers and acquisitions, venture capital, private equity, licensing and distribution, commercial contracts, intellectual property and dispute resolution. They are supported by teams from our real estate and employment departments.

We advise clients across a variety of development stages from working with start-ups, to advising companies and investors participating in early-stage funding rounds (including EIS and SEIS investment), to carrying out international structuring, to acting on international manufacturing, licencing and distribution arrangements.

We offer expert advice on:

  • Company incorporation (domestic and international)
  • Funding rounds (including seed rounds, EIS, SEIS, Series A and Series B)
  • Debt financing
  • Joint ventures, collaboration and commercialisation arrangements
  • Commercial agreements for research, clinical trials, manufacture, supply, distribution, licensing and technology transfer
  • Company, product and intellectual property acquisitions, sales and licencing
  • Intellectual property dispute resolution
  • Employment
  • Immigration
  • Real estate and construction

Our healthcare and life science team’s experience includes:

  • Advised Zhejiang Silk Road Fund, a private equity fund, on its participation in CMR Surgical Ltd $ 100m Series B funding round believed to be Europe largest ever fundraising in the medical devices industry to date. As featured in The Lawyer Monthly’s “What’s happening in the world of M&A transactions” – Oct 2018
  • Advised Tictrac, a medtech company focused on health and wellness software, on its investment by Aviva.
  • Advised the shareholders of System Analytic Limited, a healthcare analytics company, on their sale to Suddler & Hennesey (subsidiary of listed WPP plc).
  • Advised the shareholders of Galliard Healthcare in their sale to United Drug (UDG Plc).
  • Advised UroPharma, a specialist drug delivery company, on numerous investment rounds, collaboration agreements, manufacturing, licencing and distribution arrangements and an international restructuring.
  • Advised Access Fertility, the largest provider of IVF programmes in the UK, on its financial services joint venture with Merchant Money; as well as on an international restructuring and collaboration agreements with various IVF clinics domestically and internationally.
  • Advised Axon Healthcare Investments on numerous domestic and international investments in the biotech and healthcare sector.
  • Advised Roche in connection with its acquisition of medical equipment assets out of administration.
  • Advised Antev, a biotechnology company with a focus on urology, in connection with several initial funding rounds and asset acquisitions.
  • Advised INmuneBio Inc, a clinical stage biotechnology company developing immunotherapies to fight cancer, in connection with material transfer and licence agreements relating to umbilical cord tissue samples.
  • Advised Viramal, a biotechnology company with a portfolio of hormone therapies, in connection with several funding rounds.
  • Advised on the IPO of Clovis Pharma, a biopharmaceutical company focused on acquiring, developing and commercialising cancer treatments.
Stephen Hall
Senior Associate, Head of Immigration
+44 20 7539 7310
View profile
Peter Kohl
Head of Corporate
+44 20 7539 7082
View profile
Robert Paydon
Head of Commercial Litigation
+44 20 7539 7280
View profile
Zane Shihab
Head of Sport, IP & Media
+44 20 7539 7312
View profile
Yvonne Costello
Partner, Corporate
+44 20 7539 7098
View profile
Martin O'Donoghue
Partner, Corporate
+44 20 7539 7268
View profile
Arthur Horsfall
Solicitor, Corporate
+44 20 7539 7084
View profile
Ben McLaughlin
Associate Solicitor, Sports, Media & IP
+44 20 7539 7253
View profile

Key Contacts

Peter Kohl
Head of Corporate
+44 20 7539 7082
Robert Paydon
Head of Commercial Litigation
+44 20 7539 7280
Zane Shihab
Head of Sport, IP & Media
+44 20 7539 7312
Martin O'Donoghue
Partner, Corporate
+44 20 7539 7268

Related News, Insights and Events

September 4, 2020

Government ‘Build Build Build’ Reforms under review following challenge by Campaign Group

Read more
August 14, 2020

Court convened scheme meetings in the time of COVID-19

Read more
August 13, 2020

Intellectual property considerations in light of Brexit

Read more
Latest from @Kerman&Co

As the end of 2020 fast approaches, our minds now turn back to the implications of Brexit. In this article we seek… https://t.co/JpM4Xfw1Dp https://t.co/JpM4Xfw1Dp

Latest deal from our Capital Markets team advising our long-standing AIM-quoted client, Columbus Energy Resources P… https://t.co/MBttEjLQHF https://t.co/MBttEjLQHF

How can we help?

Would you like our experts to assist you with your legal requirements?

  • By completing this form you agree to your details being used to email you the information requested in accordance with our Privacy Policy.